Get startedLog in
    Picture of Medincell SA logo

    MEDCL — Medincell SA News Story

    0.000.00%
    fr flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapSucker Stock
    All News

    Teva and Medincell's schizophrenia drug meets main goal of late-stage study

    Picture of Medincell SA logoMedincell SA
    08/05/2024 11:36
    May 8 (Reuters) - Teva Pharmaceuticals  TEVA.TA 
 TEVA.K  and partner Medincell  MEDCL.PA  said on Wednesday
their experimental schizophrenia drug had met its main goal in a
late-stage study. 

 (Reporting by Puyaan Singh; Editing by Devika Syamnath)
 ((Puyaan.Singh@thomsonreuters.com;))

    Recent news on Medincell SA

    See all news